ArticleThe American journal of case reports2022
First Case of Occipital Neuralgia Treated by Fascial Hydrodissection.
Article in The American journal of case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 9 citations in OpenAlex.
- Review
- Ultrasound-guided hydrodissection combined with radiofrequency for refractory occipital neuralgia: clinical outcomes, durability, and factors associated with repeat intervention.Frontiers in neurology · 2026Article
- Ultrasound-guided continuous radiofrequency ablation of the proximal greater occipital nerve is effective in refractory occipital neuralgia: a retrospective cohort study.Arquivos de neuro-psiquiatria · 2025Article
- Effective Acupuncture in Treating Decade-Long Occipital Neuralgia in an Elderly Patient.The American journal of case reports · 2024Article
- Novel Ultrasound-Guided Hydrodissection with 5% Dextrose for the Treatment of Occipital Neuralgia Targeting the Greater Occipital Nerve.Diagnostics (Basel, Switzerland) · 2024Article
- MSK Ultrasound - An IJSPT Perspective.International journal of sports physical therapy · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND The injection technique "hydrodissection" has been used to isolate the nerves from their surrounding structures, such as the fascia, to treat nerve entrapment. However, no study has reported the use of hydrodissection for the treatment of occipital neuralgia. This report presents the first case of occipital neuralgia treated by ultrasound-guided hydrodissection of the fascia. CASE REPORT An 81-year-old woman presented to the Emergency Department with severe, paroxysmal, stabbing pain headache lasting 4 days. Under a diagnosis of occipital neuralgia, we performed ultrasound-guided hydrodissection of the right semispinalis capitis, obliquus capitis inferior, and sternocleidomastoid muscles, wherein the trigger points were palpated using a low-dose anesthetic agent (9 mL saline and 1 mL 1% lidocaine). Her headache disappeared immediately after treatment. Subsequently, the headache would recur every few days; however, the pain intensity had decreased, and the patient could tolerate it. The same hydrodissection procedure was performed on days 2, 6, and 10 after the initial visit using 2000 mg acetaminophen and 120 mg loxoprofen per day, and the headache episodes disappeared. Treatment was discontinued 23 days after the initial visit; the patient was followed up for 4 weeks, and no headache recurrence was observed. CONCLUSIONS We found that fascial hydrodissection was an effective treatment option for occipital neuralgia attributed to myofascial pain syndrome. The risk of local anesthetic poisoning was very low. Fascial hydrodissection is recommended as a new treatment for occipital neuralgia. Treatment with hydrodissection may be applicable to other neuralgia types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.